investordatabase.org

Bija Ventures

bija.vc Direct investor

Bija Ventures is a venture firm that invests at the pre-Series A stage in therapeutic platform companies with a technology or data edge, from development-candidate nomination to first-in-human trials. It acts as an active co-investor and does not need to lead.

Bija Ventures is a venture capital firm headquartered in Aspen, United States. It invests directly in companies, from seed to Series A, in therapeutics, biotech, neurology and oncology. 5 portfolio companies, as it reports.

“Bija Ventures backs founders building therapeutic platform companies with a technology or data edge, from the last preclinical push into first-in-human trials.”

— Bija Ventures, own website
Layer
Direct investor
Type
Venture capital
Stage
Seed – Series A
Headquarters
Aspen, United States
Invests in
United States, Canada, United Kingdom, Australia
Sectors
therapeutics, biotech, neurology, oncology, cardiology, immunotherapy, regenerative medicine
Portfolio
5 companies
How to reach it
Its pitch / apply page on its own site

Team, as Bija Ventures publishes it

  • Nelly Weiser General Partner
  • Colin Maraganore General Partner

Names and roles exactly as listed on bija.vc. Nothing else about these people is recorded.

Named by events

Each event below names or links Bija Ventures on its own website — as the firm of a speaker, a partner or a listed investor. The event is the source, not the investor; it says nothing about who will be in the room.

Where this comes from

Every fact above was read from a page Bija Ventures publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

  • https://www.bija.vc/name, is_investor, layer, type, hq_country, hq_city, invests_in_geographies, stage_min, stage_max, sectors, thesis_quote, description, portfolio_count, people, status, approach_url
Is this record wrong or stale?
— it reaches us directly, no email address to look up.

Record 22135 · added 2026-11-17 · link last verified 2026-11-17 · confidence high

Similar investors

Listed under